• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
1. (U4C3L1:Q1) Study the table and indicate t
1. (U4C3L1:Q1) Study the table and indicate t

... B) "Cold turkey because you stop taking drugs immediately." C) "Detoxification centers because health care professionals help you quit the drugs safely." D) "If you never start and you always say "No!" then you won't have to quit, and that's the best way." 4. (U4C3L1:Q4) A friend of yours just had a ...
cholinergic agonists - Nursing Pharmacology
cholinergic agonists - Nursing Pharmacology

... • Medications should be taken as ordered and not abruptly stopped • Doses should be spread evenly apart to optimize the effects of the medication • Overdosing can cause life-threatening problems. Patients should not adjust dosages unless directed by their health care provider ...
Facts about drugs booklet - Mental Health Commission
Facts about drugs booklet - Mental Health Commission

... WHY DO PEOPLE USE DRUGS? ...
Main mechanisms for drug action
Main mechanisms for drug action

... May be based on expectations Maybe be used to get more drugs an sympathy from doctors or family Protracted Withdrawal ...
Illustrated Drug interaction By Mohie Al
Illustrated Drug interaction By Mohie Al

... spasm and soreness Internal: GI tract disorders ...
NEW Psychoactive DRUGS
NEW Psychoactive DRUGS

... [ Legal status – Many psychoactive drugs were created (or marketed, if already existed) to bypass drug laws either by modifying the molecular structures of existing drugs or by developing new drugs with similar effects to illegal ones. Some NPS are not classified by existing legislation but may be s ...
club drugs: an approach to review the hazard in indian scenario
club drugs: an approach to review the hazard in indian scenario

... 2009-10. Despite this decline in overall use, around one million adults are estimated to have used club drugs in 2011-12. Ecstasy is used the most, but its popularity is waning: use is down from 502,000 in 2005-06 to 461,000 in 2011-12. Ketamine use has changed little over the last three years, hove ...
to free sample
to free sample

... to a larger dose given PO. After absorption, a drug given orally must pass through the liver before reaching the systemic circulation. In the liver, the drug undergoes metabolic changes that inactivate some of the drug. Bioavailability measures the amount of drug that was absorbed into the systemic ...
study on identification and assessment of drug interactions in
study on identification and assessment of drug interactions in

... administration of a drug combination that is different from the anticipated known effects of the two agents when given alone and that can result in reduced effectiveness or increased toxicity1. A DDI can be the consequence of various situations that reflect the growing number of drugs available in t ...
citeline Pharma r&d annual review 2015
citeline Pharma r&d annual review 2015

... which both post double-digit inflations (up 17.9% and 15.1%, respectively). Among the larger groups, Alimentary/Metabolic has the most impressive expansion, with a 9.5% growth in the number of pipeline projects. Note that throughout this section, there can be some double-counting if a drug is under ...
Light">CHAPTER
Light">CHAPTER

... to a larger dose given PO. After absorption, a drug given orally must pass through the liver before reaching the systemic circulation. In the liver, the drug undergoes metabolic changes that inactivate some of the drug. Bioavailability measures the amount of drug that was absorbed into the systemic ...
AH-7921: the list of new psychoactive opioids is expanded
AH-7921: the list of new psychoactive opioids is expanded

... scientific research [6, 12, 13], and can be ordered online from suppliers of chemicals. These licit products are, of course, not intended for human consumption. Relative labeling (‘‘analytical reference standard’’, ‘‘laboratory reagent only’’, or ‘‘not for human consumption’’) appears on some of the ...
pharmacokinetics-5
pharmacokinetics-5

... and is very slowly excreted can pose just as many problems as one that is susceptible to metabolism. • If the effects of the drug could last too long then it would cause both: → Toxicity → Lingering side effects Therefore, designing drugs with decreased chemical and metabolic stability can sometimes ...
Pharmacology of Enteral Agents
Pharmacology of Enteral Agents

... in women or animals. Drugs should be given only if the potential benefits justify the potential risks to the fetus D—there is positive evidence of fetal risk. If the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective X—the ...
Medicinal chemistry strategies in follow
Medicinal chemistry strategies in follow

... no head-to-head comparisons have been conducted in large clinical trials to demonstrate such differentiations [34]. The lower development cost, however, allows udenafil to be sold at a discounted price and gain a significant portion of the Korean market. This model is particularly popular for produc ...
Sedatives
Sedatives

...  Began looking for depressants other than alcohol.  Bromides were introduced to treat nervousness/anxiety. Very popular but toxic.  Early 1900s  Barbiturates replaced Bromides. Initially viewed as safe & effective. However, problems with tolerance, dependence, & safety became apparent.  1950s  ...
2- Distribution
2- Distribution

... Capillary permeability is determined by capillary structure and by the chemical nature of the drug. 1. Capillary structure: Capillary structure varies widely in terms of the fraction of the basement membrane that is exposed by slit (tight) junctions between endothelial cells. In the brain, the capil ...
Question Papers
Question Papers

... The drug is not included under Jeevaniya Mahakashay as refers Charak. 1) Kakoli-Ksheer kakoli 2) Mudgparni-Mashparni 3) Meda-mahameda 4) Hridhi-Vriddhi ...
A Workshop from the Program in Wise Prescribing PHARmACeUTiCAl ComPAny  PresCriber Marketing
A Workshop from the Program in Wise Prescribing PHARmACeUTiCAl ComPAny PresCriber Marketing

... 3. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: Interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-243. 4. Chren MM, Landefeld CS, Physicians behavior and their interactions with drug companies: a controlled study of physician ...
Adverse Drug Events: A Perspective
Adverse Drug Events: A Perspective

... drugs as those Rights the Public unsafe for selfHealth medication and Drug manufacturers Service. which should were required to be used only prove to FDA the under a safety and doctor’s effectiveness of supervision their products before marketing them. Consumer Bill of Rights (informed consent) ...
IN VITRO ANTIMICROBIAL ACTIVITY OF THE SIDDHA DRUGS SEENTHIL SARKARAI... NILAVEMBU KUDINEER AGAINST LEPTOSPIRA
IN VITRO ANTIMICROBIAL ACTIVITY OF THE SIDDHA DRUGS SEENTHIL SARKARAI... NILAVEMBU KUDINEER AGAINST LEPTOSPIRA

... antileptospiral activity. From the dilution of 100 µl to 2 ml , growth was observed but in the dilution of 2.5 ml full inhibition was observed. DISCUSSION It is seen worldwide upsurge in use of Siddha treatment for acute and chronic conditions for the sake of preventing the complications and to avoi ...
FORMULATION AND EVALUATION OF VINPOCETINE LOADED LIPOSPHERES  Research Article
FORMULATION AND EVALUATION OF VINPOCETINE LOADED LIPOSPHERES Research Article

... The aim of this study was to prepare and evaluate vinpocetine loaded lipospheres by emulsion method. The lipospheres carrier system has several advantages over other delivery systems in term of physical stability and low cost of ingredients. Vinpocetine is selected because it is best known for its n ...
Development of new drugs for chemoprophylaxis of malaria.
Development of new drugs for chemoprophylaxis of malaria.

... mefloquine (WR149240) with Hoffman LaRoche as the codevelopment partner. Licensed in the USA in 1988, mefloquine (Lariam®) remains the malaria prophylaxis of choice for US soldiers and travelers. Resistance to mefloquine has been documented in Indochina, East Africa and sporadic cases are occurring ...
Drug Excretion and Clearance
Drug Excretion and Clearance

... Minor Routes of Drug Excretion Drugs are primarily excreted by passive diffusion. Salivary Gland drug excretion may produce toxicity to oral mucosa and teeth. Mammary Gland drug excretion will contaminate milk [mother and cows] consumed by individuals. Sweat Glands major route of drug elimination in ...
Chronotropic Effects of Select Cardiovascular Drugs on the
Chronotropic Effects of Select Cardiovascular Drugs on the

... An experiment was performed to investigate the effects of two known cardiovascular drugs on the developing 4-chambered vertebrate heart using the embryonic chicken as the model system. Ninety percent of pregnant women take some type of drug: whether that is prescription, over-the-counter, or social ...
< 1 ... 98 99 100 101 102 103 104 105 106 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report